Echosens produces diagnostic and therapeutic monitoring devices, such as Fibroscan and Agile 3+, to support physicians in monitoring chronic liver diseases. Their FibroScan is recognized worldwide as the reference for liver fibrosis and liver steatosis assessment, with more than 2,500 peer-reviewed publications and 60 international guidelines recommendations. Echosens has made FibroScan available in over 100 countries, enabling millions of liver examinations worldwide. They also work with physicians, medical academic research, and pharmaceutical companies for patient identification and monitoring in NAFLD/NASH. Echosens has created the "myliverexam" website to provide information about the role of the liver and why it is vital to global health, as patient education is a major issue.